Warp Sciences

Warp Sciences is a U.S. chemistry company combining expert chemists, AI and robotics to help research teams make molecules for drug discovery. It is building automated laboratories intended to learn from experimental results, linking compound synthesis with data collection and improved models. The business describes itself as a chemistry contract research organization, with automation designed into its laboratory workflows from the outset.

The founding leadership includes Kevin Weil as CEO, Sol Reisberg as chief scientific officer, DJ Patil as chief operating officer and Manohar Paluri as chief technology officer. Warp launched publicly in October 2026 with a $215 million Series A led by Lightspeed. Its website says it is working with a small number of design partners as capacity opens. The programme targets more U.S.-based experimental capacity, while the extent of autonomous operation and delivered laboratory output remains separate from the financing announcement.